140 related articles for article (PubMed ID: 32947155)
1. Cancer risk in patients with primary immune thrombocytopenia - A Swedish nationwide register study.
Ekstrand C; Bahmanyar S; Cherif H; Kieler H; Linder M
Cancer Epidemiol; 2020 Dec; 69():101806. PubMed ID: 32947155
[TBL] [Abstract][Full Text] [Related]
2. Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease-specific treatments: a French nationwide cohort study.
Lafaurie M; Maquet J; Baricault B; Ekstrand C; Christiansen CF; Linder M; Bahmanyar S; Nørgaard M; Sailler L; Lapeyre-Mestre M; Sommet A; Moulis G
Br J Haematol; 2021 Nov; 195(3):456-465. PubMed ID: 34386974
[TBL] [Abstract][Full Text] [Related]
3. Increased susceptibility to infections before the diagnosis of immune thrombocytopenia.
Ekstrand C; Linder M; Cherif H; Kieler H; Bahmanyar S
J Thromb Haemost; 2016 Apr; 14(4):807-14. PubMed ID: 26792007
[TBL] [Abstract][Full Text] [Related]
4. Immune thrombocytopenia and risk of stroke: Evidence from a nationwide population-based cohort study.
Chen HY; Lee WK; Chang R; Hung YM; Hsu CY; Shih YH; Chen JS
Int J Stroke; 2023 Apr; 18(4):408-415. PubMed ID: 36073612
[TBL] [Abstract][Full Text] [Related]
5. Twenty-year mortality of adult patients with primary immune thrombocytopenia: a Danish population-based cohort study.
Frederiksen H; Maegbaek ML; Nørgaard M
Br J Haematol; 2014 Jul; 166(2):260-7. PubMed ID: 24690142
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer in Crohn's disease: a Scandinavian population-based cohort study.
Olén O; Erichsen R; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sørensen HT; Ludvigsson JF
Lancet Gastroenterol Hepatol; 2020 May; 5(5):475-484. PubMed ID: 32066530
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of immune thrombocytopenic purpura among inpatients with coeliac disease.
Olén O; Montgomery SM; Elinder G; Ekbom A; Ludvigsson JF
Scand J Gastroenterol; 2008; 43(4):416-22. PubMed ID: 18365906
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors.
Ruggeri M; Tosetto A; Palandri F; Polverelli N; Mazzucconi MG; Santoro C; Gaidano G; Lunghi M; Zaja F; De Stefano V; Sartori R; Fazi P; Rodeghiero F;
J Thromb Haemost; 2014 Aug; 12(8):1266-73. PubMed ID: 24942752
[TBL] [Abstract][Full Text] [Related]
9. Immune thrombocytopenic purpura increased risk of subsequent pancreatitis: A Nationwide population cohort study.
Wu SC; Lin SF; Fang CW; Tsai IJ; Yang WC
Sci Rep; 2019 Nov; 9(1):16923. PubMed ID: 31729447
[TBL] [Abstract][Full Text] [Related]
10. Primary immune thrombocytopenia (ITP) treated with romiplostim in routine clinical practice: retrospective study from the United Kingdom ITP Registry.
Doobaree IU; Newland A; McDonald V; Nandigam R; Mensah L; Leroy S; Seesaghur A; Patel H; Wetten S; Provan D
Eur J Haematol; 2019 May; 102(5):416-423. PubMed ID: 30758874
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological agents preceding a diagnosis of immune thrombocytopenia in adult patients developing the chronic form: A Swedish national register study.
Löfling L; Linder M; Ekstrand C; Cherif H; Kieler H; Bahmanyar S
Thromb Res; 2017 Dec; 160():27-31. PubMed ID: 29091809
[TBL] [Abstract][Full Text] [Related]
12. Long-term clinical outcomes of patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study.
Nørgaard M; Jensen AØ; Engebjerg MC; Farkas DK; Thomsen RW; Cha S; Zhao S; Sørensen HT
Blood; 2011 Mar; 117(13):3514-20. PubMed ID: 21263148
[TBL] [Abstract][Full Text] [Related]
13. Substance use disorders in refugee and migrant groups in Sweden: A nationwide cohort study of 1.2 million people.
Harris S; Dykxhoorn J; Hollander AC; Dalman C; Kirkbride JB
PLoS Med; 2019 Nov; 16(11):e1002944. PubMed ID: 31689291
[TBL] [Abstract][Full Text] [Related]
14. Fatigue in adult patients with primary immune thrombocytopenia.
Newton JL; Reese JA; Watson SI; Vesely SK; Bolton-Maggs PH; George JN; Terrell DR
Eur J Haematol; 2011 May; 86(5):420-9. PubMed ID: 21323737
[TBL] [Abstract][Full Text] [Related]
15. Malaria and risk of lymphoid neoplasms and other cancer: a nationwide population-based cohort study.
Wyss K; Granath F; Wångdahl A; Djärv T; Fored M; Naucler P; Färnert A
BMC Med; 2020 Oct; 18(1):296. PubMed ID: 33121475
[TBL] [Abstract][Full Text] [Related]
16. Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia.
Mahévas M; Gerfaud-Valentin M; Moulis G; Terriou L; Audia S; Guenin S; Le Guenno G; Salles G; Lambotte O; Limal N; Viallard JF; Cheze S; Tomowiak C; Royer B; Neel A; Debouverie O; Hot A; Durieu I; Perlat A; Cliquennois M; Deteix C; Michel M; Godeau B
Blood; 2016 Sep; 128(12):1625-30. PubMed ID: 27354722
[TBL] [Abstract][Full Text] [Related]
17. Infections in non-splenectomized persistent or chronic primary immune thrombocytopenia adults: risk factors and vaccination effect.
Moulis G; Lapeyre-Mestre M; Palmaro A; Sailler L
J Thromb Haemost; 2017 Apr; 15(4):785-791. PubMed ID: 28078756
[TBL] [Abstract][Full Text] [Related]
18. Immune thrombocytopenic purpura presenting in a patient after renal transplant for diabetic nephropathy.
Rashid RM; Nabi Z; Ansari AZ; Qaiser QA
BMC Nephrol; 2018 Mar; 19(1):69. PubMed ID: 29554892
[TBL] [Abstract][Full Text] [Related]
19. Atopic dermatitis and association of risk for primary immune thrombocytopenia and autoimmune diseases among children: A nationwide population-based cohort study.
Wei CC; Lin CL; Shen TC; Tsai JD
Medicine (Baltimore); 2016 Jul; 95(29):e4226. PubMed ID: 27442647
[TBL] [Abstract][Full Text] [Related]
20. Effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patients with immune thrombocytopenia.
Zeller MP; Heddle NM; Kelton JG; Hamilton K; Wang G; Sholapur N; Carruthers J; Hsia C; Blais N; Toltl L; Hamm C; Pearson MA; Arnold DM
Transfusion; 2016 Jan; 56(1):73-9. PubMed ID: 26400824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
